vTv Therapeutics Starts Phase 2a Diabetes Study
The company has randomized the first participant in a pilot trial testing cadisegliatin in Type 1 diabetes patients.
Live Poll
Is now a good time to participate in experimental clinical trials for chronic condition treatments?